Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.47
+0.04 (0.28%)
May 7, 2026, 12:59 PM EDT - Market open

Adaptive Biotechnologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,3162,4978877111,0933,968
Market Cap Growth
122.34%181.67%24.72%-34.98%-72.44%-51.25%
Enterprise Value
2,2802,347743.27453.77693.833,721
Last Close Price
14.4716.246.004.907.6428.06
PE Ratio
--41.64-5.56-3.14-5.46-18.96
PS Ratio
7.829.024.954.185.9025.71
PB Ratio
10.6511.414.372.312.366.57
P/TBV Ratio
10.4311.264.352.292.356.52
P/FCF Ratio
--51.02-8.97-4.26-5.46-15.59
P/OCF Ratio
--54.31-9.31-4.55-5.94-20.59
EV/Sales Ratio
7.728.474.152.663.7424.11
EV/EBITDA Ratio
--59.73-5.19-2.22-3.87-19.08
EV/EBIT Ratio
--41.08-4.57-2.00-3.47-17.81
EV/FCF Ratio
--47.95-7.52-2.72-3.46-14.62
Debt / Equity Ratio
0.310.310.390.290.210.18
Debt / EBITDA Ratio
-2.61-2.01-0.62-0.48-0.60-0.57
Debt / FCF Ratio
-2.63-1.62-0.90-0.59-0.54-0.44
Net Debt / Equity Ratio
-0.65-0.68-0.66-0.80-0.84-0.40
Net Debt / EBITDA Ratio
4.723.760.931.212.181.24
Net Debt / FCF Ratio
4.763.021.341.481.950.95
Asset Turnover
0.580.530.300.220.210.15
Inventory Turnover
6.957.826.305.233.442.96
Quick Ratio
3.063.082.694.374.903.26
Current Ratio
3.353.342.894.665.123.54
Return on Equity (ROE)
-22.10%-27.82%-62.49%-58.34%-37.52%-30.77%
Return on Assets (ROA)
-9.17%-10.86%-27.08%-29.92%-22.49%-20.49%
Return on Invested Capital (ROIC)
-18.01%-21.14%-56.98%-74.84%-46.34%-44.38%
Return on Capital Employed (ROCE)
-11.10%-13.22%-32.05%-34.40%-25.72%-22.95%
Earnings Yield
-2.15%-2.40%-18.00%-31.84%-18.32%-5.27%
FCF Yield
-1.28%-1.96%-11.15%-23.49%-18.32%-6.41%
Buyback Yield / Dilution
-3.62%-3.14%-1.88%-1.31%-1.54%-6.96%
Total Shareholder Return
-3.62%-3.14%-1.88%-1.31%-1.54%-6.96%
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q